nutrition researchVitamins A, B, C, D, E: The Honest Guide to the Big-Five Stack

In 1994, the New England Journal of Medicine published the ATBC Cancer Prevention Study — a Finnish trial of 29,133 male smokers randomized to beta-carotene, alpha-tocopherol, both, or placebo. After five to eight years, the beta-carotene arm had 18% more lung cancer cases than placebo. Lung cancer mortality was 8% higher. The trial was stopped early. The CARET trial replicated the finding two years later in U.S. smokers.

The lesson was not that beta-carotene is poisonous. The lesson was that a single isolated nutrient delivered at supraphysiological doses, divorced from the food matrix where it normally exists, behaves differently from the nutrient as found in vegetables. The vitamin world is full of similar pitfalls — and the generic A-through-E multivitamin sits squarely in the middle of them.

Vitamin A: Preformed vs Precursor — Why the Form Matters#

Vitamin A exists in two functional forms. Preformed vitamin A (retinol, retinyl palmitate, retinyl acetate) is the direct active molecule found in liver, fatty fish, eggs, and dairy. Beta-carotene and other carotenoids are precursors found in orange and dark leafy vegetables — the body converts them to retinol via beta-carotene 15,15'-monooxygenase.

The conversion is inefficient and highly variable. The current dietary reference intake assumes a 12:1 ratio of beta-carotene to retinol activity equivalents, but individual conversion rates range from 6:1 in efficient converters to 28:1 in poor converters. Roughly 45% of adults carry a BCMO1 polymorphism that reduces conversion efficiency by 30–50%. A diet "rich in beta-carotene" does not reliably produce adequate vitamin A status in this subpopulation.

The supplement implications are direct. Preformed vitamin A is potent and accumulates — the upper tolerable limit is 3,000 mcg RAE/day in adults. Above 10,000 IU (3,000 mcg) chronically, hepatotoxicity, bone loss, and (during pregnancy) teratogenicity become concerns. Beta-carotene from food is essentially non-toxic — excess accumulates harmlessly in skin and adipose. But high-dose isolated beta-carotene supplements, as ATBC and CARET showed, are not harmless in smokers and possibly former smokers.

The practical conclusion: get vitamin A from food (liver, eggs, dairy, dark leafy and orange vegetables). Avoid standalone high-dose retinol or beta-carotene supplements unless treating a documented deficiency. Most men consuming any animal products are vitamin A replete; deficiency is rare outside of malabsorption syndromes and strict vegan diets without adequate carotenoid intake.

Vitamin B Complex: Methylation Status Changes the Game#

The B vitamins are not a single nutrient. They are eight distinct molecules — B1 (thiamine), B2 (riboflavin), B3 (niacin/niacinamide), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folate), B12 (cobalamin) — with overlapping but distinct functions. The most clinically important variables are B12, folate, and B6, and their interaction through the methylation cycle.

Methylation is the cellular process of attaching methyl groups to DNA, neurotransmitters, hormones, and membrane phospholipids. Folate and B12 together drive this cycle through the conversion of homocysteine back to methionine. When the cycle runs poorly, homocysteine rises — and elevated homocysteine is independently associated with cardiovascular disease, cognitive decline, and depression.

The MTHFR enzyme converts folate into 5-methyltetrahydrofolate (5-MTHF), the active form. The C677T polymorphism reduces enzyme activity to 70% (heterozygous) or 30% (homozygous). The A1298C variant has a similar but milder effect. Wilcken's 2003 review in the Journal of Medical Genetics showed that 40–60% of populations carry at least one variant.

For these individuals, standard supplemental folic acid is partially wasted — it must be converted through MTHFR before it can be used, and the bottleneck is exactly what's compromised. Methylfolate (L-methylfolate or 5-MTHF) bypasses the enzyme and delivers the active form directly. The same applies to B12: cyanocobalamin is cheap and shelf-stable but requires conversion; methylcobalamin and adenosylcobalamin are the active forms.

P5P (pyridoxal-5-phosphate) is the active form of B6 and the cofactor for over 100 enzyme reactions including neurotransmitter synthesis. Standard pyridoxine HCl works for most men but methylation-impaired patients respond more reliably to P5P.

Dosing: a high-quality B-complex with methylated forms typically supplies 400–800 mcg methylfolate, 500–1,000 mcg methylcobalamin, 50 mg P5P, and modest doses of the remaining B vitamins. Once daily with breakfast is standard. The water-soluble B vitamins are not stored long-term — consistent intake matters more than dose magnitude.

The men who benefit most: those with elevated homocysteine, documented MTHFR variants, chronic alcohol use (which depletes B vitamins), age over 60 (intrinsic factor decline reduces B12 absorption), strict vegan or vegetarian diets, and those on metformin or proton pump inhibitors (both deplete B12).

Vitamin C: Saturation, Tolerance, and the Cold Question#

Vitamin C is the most heavily marketed and most over-claimed vitamin in the category. The actual biology is well-defined.

Vitamin C is a water-soluble antioxidant and an essential cofactor for collagen synthesis, neurotransmitter synthesis (norepinephrine, serotonin), and iron absorption. Severe deficiency causes scurvy — a disease that requires sustained intake below ~10 mg/day for weeks. The RDA of 90 mg/day in adult men prevents scurvy with margin.

Plasma vitamin C saturates at oral intakes of around 200–400 mg/day. Above this, absorption efficiency falls and the excess is excreted in urine. Doses above 1 g/day produce diminishing plasma increases and rising GI side effects — loose stools, cramping, and what's called "bowel tolerance."

The common cold question has been studied repeatedly. Hemilä and Chalker's 2013 Cochrane review of 29 trials concluded routine vitamin C supplementation does not reduce common cold incidence in the general population. It does reduce duration by approximately 8% in adults and 14% in children when taken daily — a modest, real effect. Therapeutic dosing started after symptoms appear shows no consistent benefit.

The form matters less than marketing suggests. Liposomal vitamin C does improve plasma levels modestly at higher doses but the clinical relevance is unclear. Buffered ascorbates (sodium ascorbate, calcium ascorbate) reduce GI side effects at higher doses without changing efficacy. Plain ascorbic acid at 500 mg–1 g/day, divided, is sufficient for the use cases where vitamin C actually matters.

Doses above 2 g/day chronically may increase kidney stone risk in susceptible men and have shown weak signals of pro-oxidant activity in cell culture. The 1–2 g/day range is the practical ceiling for routine use.

Vitamin D: The Real Deficiency Story#

Vitamin D is the supplement with the strongest deficiency case in the modern adult population. NHANES data consistently shows 30–40% of U.S. adults have serum 25(OH)D below 20 ng/mL (the deficiency threshold), and 60–70% are below 30 ng/mL (the insufficiency threshold). Above 40°N latitude, winter status is functionally universal.

The biology spans far beyond bone metabolism. Vitamin D receptors are present in nearly every tissue. Low status is associated with impaired immune function, increased autoimmune risk, depressed mood, reduced testosterone (Pilz 2011 showed 25(OH)D and testosterone co-vary), and elevated all-cause mortality across cohort studies. Whether supplementation reverses all these associations is more contested than the supplement industry implies, but the deficiency burden is real and the supplementation is cheap.

Heaney's dose-response work established that adults require approximately 1,000 IU daily for every 10 ng/mL of serum 25(OH)D desired above baseline. Starting from typical deficient adult baseline (15–20 ng/mL), reaching the 40–60 ng/mL target zone requires 4,000–6,000 IU/day. The IOM's 600 IU RDA prevents rickets but does not optimize.

D3 (cholecalciferol) outperforms D2 (ergocalciferol). The half-life is longer, the receptor affinity is higher, and equivalent doses produce larger increases in 25(OH)D. D2 is included in fortified foods primarily because it is cheaper to produce; for supplementation, D3 is the only form that should be used.

Vitamin K2 is the critical co-supplement. D3 increases calcium absorption from the gut; K2 (specifically menaquinone-7, MK-7) activates osteocalcin and matrix Gla protein, directing absorbed calcium into bone matrix and away from arterial walls. Beulens' 2009 cohort study showed that higher dietary K2 intake was associated with reduced coronary artery calcification — the K2 + D3 combination addresses the theoretical concern that high-dose D3 alone might accelerate vascular calcification in K-insufficient adults.

Protocol: D3 5,000 IU daily plus MK-7 100 mcg daily, taken with the largest meal of the day (both are fat-soluble). Retest 25(OH)D at 12 weeks and adjust toward the 40–60 ng/mL window. See the vitamin D biomarker for the testing context.